Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 45: 1129-1130, 1999;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Parker, W. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Parker, W. D., Jr
Related Collections
Right arrow Molecular Diagnostics and Genetics
(Clinical Chemistry. 1999;45:1129-1130.)
© 1999 American Association for Clinical Chemistry, Inc.

Editorials

The Other Genome

W. Davis Parker Jr

Departments of Neurology and Pediatrics, and the Center for the, Study of Neurodegenerative Disorders, University of Virginia School of Medicine, Charlottesville, VA 22901, E-mail dp8m@virginia.edu

Since the discovery that Leber hereditary optic neuropathy (LHON) results from mutations in mitochondrial DNA (mtDNA), considerable attention has been focused on this alternative genome and on development of the scientific tools needed to study this remarkable genetic pathway (1)(2). In this issue, Chen et al. (3) describe the application of temporal temperature gradient gel electrophoresis to the detection of mtDNA mutations and show that this technique offers great promise in this application.

The study of mitochondrial gene mutations presents investigators with new technical problems not inherent to the study of nuclear gene mutations. This genome is thought to be derived from an evolutionarily ancient organism that parasitized primitive cells, conferring on them enhanced oxidative capacity and the capability of making profitable use of atmospheric oxygen, a fairly toxic substance. The structure of the present day human mitochondrial genome reflects its unusual origin. The mitochondrial genome is a small (16.5 kb) circular DNA encoding only 13 proteins, 2 rRNAs, and a set of tRNAs. All proteins encoded by the mitochondrial genome are components of the mitochondrial electron transport chain, the energy-transducing, oxidative apparatus of the cell. Unlike nuclear genes, which exist in pairs by virtue of their location on paired chromosomes, mitochondrial genes exist in numerous copies per cell, with each mitochondrion containing several copies of the genome and each cell containing many mitochondria. In the case of a nuclear gene, only a limited number of combinations of mutated genes are possible: a situation in which . . . [Full Text of this Article]


References






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American Association for Clinical Chemistry.